Genscript Biotech Corporation (HKG:1548)

Genscript Biotech Revenue

Genscript Biotech had revenue of $404.22M USD in the half year ending June 30, 2026, with 41.75% growth. This brings the company's revenue in the last twelve months to $844.97M, up 2.04% year-over-year. In the year 2025, Genscript Biotech had annual revenue of $959.53M with 61.40% growth.

• Revenue (ttm): $844.97M
• Revenue Growth: +2.04%
• P/S Ratio: 12.00
• Revenue / Employee: $137.73K
• Employees: 6,135
• Market Cap: 79.51B HKD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	959.53M	365.04M	61.40%
Dec 31, 2024	594.49M	34.01M	6.07%
Dec 31, 2023	560.48M	-65.22M	-10.42%
Dec 31, 2022	625.70M	135.60M	27.67%
Dec 31, 2021	490.10M	99.25M	25.39%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 31, 2026

Data Sources Report a data error